🟢 Marker Therapeutics is trading 7.5% up in pre-market amid broader strength; no company-specific catalyst identified

Marker Therapeutics is trading 7.50% up now at $1.29, with the move appearing more consistent with broader pre-market strength than a company-specific catalyst.

• No September 10 or September 11, 2026 company-specific announcement was identified.
• The official release page lists its latest 2026 release on March 18, with no newer filing or press release shown.
• Major U.S. indices are up more than 0.5%; volume and activity details were unavailable, limiting confidence.